TY  - GEN 
AU  - Gladman, D. D.
AU  - Orbai, A. M.
AU  - Gómez-Reino Carnota, Juan Jesús
AU  - Chang-Douglass, S.
AU  - Leoncini, E.
AU  - Burton, H. E.
AU  - Kanik, K. S.
AU  - Romero, A. B.
AU  - Cappelleri, J. C.
AU  - Hsu, M. A.
PY  - 2020
SN  - 0011-393X
UR  - http://hdl.handle.net/20.500.11940/16509
AB  - Background: Tofacitinib and other new treatments approved for use in psoriatic arthritis have only recently been included in psoriatic arthritis treatment guidelines, and studies evaluating the relative efficacy of available therapies are important to...
TI  - Network Meta-Analysis of Tofacitinib, Biologic Disease-Modifying Antirheumatic Drugs, and Apremilast for the Treatment of Psoriatic Arthritis
DO  - 10.1016/j.curtheres.2020.100601
KW  - IDIS
VL  - 93.
ER  -